SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-003751
Filing Date
2004-08-03
Accepted
2004-08-03 11:19:10
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 PENWEST PHARMACEUTICALS CO. b51168ppe10vq.htm 10-Q 254434
2 EX-3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION b51168ppexv3w1.txt EX-3.1 15364
3 EX-10.1 LEASE AMENDMENT DATED MARCH 15, 2004 b51168ppexv10w1.txt EX-10.1 16594
4 EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b51168ppexv31w1.txt EX-31.1 3608
5 EX-31.2 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER b51168ppexv31w2.txt EX-31.2 3703
6 EX-32.1 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b51168ppexv32w1.txt EX-32.1 1252
7 EX-32.2 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER b51168ppexv32w2.txt EX-32.2 1333
  Complete submission text file 0000950135-04-003751.txt   298815
Mailing Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120
Business Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120 877-736-9378
PENWEST PHARMACEUTICALS CO (Filer) CIK: 0001047188 (see all company filings)

IRS No.: 911513032 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23467 | Film No.: 04947094
SIC: 2834 Pharmaceutical Preparations